trial · primary record
Cemiplimab
Metastatic NSCLC - Non-Small Cell Lung Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 156 |
| Primary completion | 2030-09 |
| Primary endpoint | Progression-free survival (PFS) |
| Registry ID | NCT07020065 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:54.877Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07020065
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Cemiplimab · compound